Reuters logo
BRIEF-MDxHealth identifies men at increased risk of prostate cancer recurrence
March 27, 2017 / 5:44 AM / 8 months ago

BRIEF-MDxHealth identifies men at increased risk of prostate cancer recurrence

March 27 (Reuters) - MDxHealth SA:

* Mdxhealth epigenetic biomarkers identify men at increased risk of prostate cancer recurrence

* Biomarkers from ConfirmMDx for prostate cancer test could help urologists monitor therapy response to improve personalized treatment of castration resistant prostate cancer Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below